New 10% liquid intravenous immunoglobulin in multifocal motor neuropathy: Prospective study of efficacy, safety and tolerability

被引：0
|
作者：
Cats, E. A. [1 ]
van der Pol, W. L. [1 ]
van den Berg-Vos, R. M. [1 ]
Wokke, J. H. J. [1 ]
Franssen, H. [1 ]
van den Berg, L. H. [1 ]
机构：
[1] UMC Utrecht, Utrecht, Netherlands
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2008年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [31] Chronic Severe Neutropenia Associated With Intravenous Immunoglobulin for Multifocal Motor Neuropathy
    Ugarte, Shannon
    Gebhard, Talia
    Cornblath, David R.
    Scherer, Steven S.
    Babushok, Daria V.
    EJHAEM, 2025, 6 (01):
  • [32] Multifocal motor neuropathy. Immediate response to intravenous immunoglobulin.
    Cammarota, A
    Nogues, M
    Rivero, A
    Garcia, H
    MEDICINA-BUENOS AIRES, 2001, 61 (04) : 441 - 444
  • [33] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MULTIFOCAL MOTOR NEUROPATHY
    NOBILEORAZIO, E
    MEUCCI, N
    BARBIERI, S
    CARPO, M
    SCARLATO, G
    NEUROLOGY, 1993, 43 (03) : 537 - 544
  • [34] Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency
    Joseph A. Church
    Heinz Leibl
    Mark R. Stein
    Isaac R. Melamed
    Arye Rubinstein
    Lynda C. Schneider
    Richard L. Wasserman
    Borislava G. Pavlova
    Karl Birthistle
    Marianne Mancini
    Sandor Fritsch
    Lisa Patrone
    Kerry Moore-Perry
    Hartmut J. Ehrlich
    Journal of Clinical Immunology, 2006, 26 : 388 - 395
  • [35] Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency
    Church, Joseph A.
    Leibl, Heinz
    Stein, Mark R.
    Melamed, Isaac R.
    Rubinstein, Arye
    Schneider, Lynda C.
    Wasserman, Richard L.
    Pavlova, Borislava G.
    Birthistle, Karl
    Mancini, Marianne
    Fritsch, Sandor
    Patrone, Lisa
    Moore-Perry, Kerry
    Ehrlich, Hartmut J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (04) : 388 - 395
  • [36] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Richard L. Wasserman
    Joseph A. Church
    Mark Stein
    James Moy
    Martha White
    Steven Strausbaugh
    Harry Schroeder
    Mark Ballow
    James Harris
    Isaac Melamed
    David Elkayam
    William Lumry
    Daniel Suez
    Syed M. Rehman
    Journal of Clinical Immunology, 2012, 32 : 663 - 669
  • [37] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Wasserman, Richard L.
    Church, Joseph A.
    Stein, Mark
    Moy, James
    White, Martha
    Strausbaugh, Steven
    Schroeder, Harry
    Ballow, Mark
    Harris, James
    Melamed, Isaac
    Elkayam, David
    Lumry, William
    Suez, Daniel
    Rehman, Syed M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (04) : 663 - 669
  • [38] Efficacy, Safety, and Tolerability of Intravenous Gammaglobulin (IGIV, 10%) in a Phase 3, Randomized, Placebo-Controlled, Cross-Over Trial for the Treatment of Multifocal Motor Neuropathy (MMN)
    Koski, Carol
    Beydoun, Said
    Schiff, Richard
    Oh, Myungshin
    Ngo, Leock
    Leibl, Heinz
    Gelmont, David
    Grp, M. M. N. Study
    Hahn, Angelika F. G.
    NEUROLOGY, 2012, 78
  • [39] Dose, exposure, and treatment regimen of intravenous immunoglobulin G in multifocal motor neuropathy
    Li, Zhaoyang
    Roepcke, Stefan
    Franke, Ryan
    Yel, Leman
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [40] Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy
    Oztekin, N. Subutay
    Oztekin, M. F.
    Orhan, G.
    Ak, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 266 - 267
12345